NEULAND LABS Fact Sheet, NEULAND LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Fact Sheet    (NELB)


Get Details: These 3 Stocks are the Dark Horses of the Stock Market


Here is the latest financial fact sheet of NEULAND LABS. For more details, see the NEULAND LABS quarterly results and NEULAND LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

NEULAND LABS Price History

Price Rs 2,025.6
Mkt Cap Rs m 25,988
Vol '000 13.3
P/E X 32.2
P/CF X 21.7
EPS (TTM) Rs 62.8
% ch % -0.5
No. of shares m 12.83
% ch week % -2.6
% ch 1-mth % 0.5
% ch 12-mth % 338.6
52 week H/L Rs 2,840.0/450.0
(As on Jun 18, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NEULAND LABS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
NEULAND LABS EQUITY SHARE DATA
High Rs1,5571,6808287542,350 
Low Rs678680431247260 
Sales per share (Unadj.) Rs641.9592.0519.7594.5730.3 
Earnings per share (Unadj.) Rs52.813.612.812.662.6 
Diluted earnings per shareRs36.59.412.812.662.6 
Cash flow per share (Unadj.) Rs74.438.533.037.093.5 
Dividends per share (Unadj.) Rs001.202.005.00 
Adj. dividends per shareRs0.000.001.202.005.00 
Dividend yield (eoy) %000.20.40.4 
Book value per share (Unadj.) Rs264.4278.4545.1553.4609.4 
Adj. book value per shareRs183.0192.7545.1553.4609.4 
Shares outstanding (eoy) m8.888.8812.8312.8312.83 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.72.01.20.81.8 
Avg P/E ratio x21.286.949.139.620.9 
P/CF ratio (eoy) x15.030.719.113.514.0 
Price / Book Value ratio x4.24.21.20.92.1 
Dividend payout %009.415.88.0 
Avg Mkt Cap Rs m9,93010,4838,0786,42116,746 
No. of employees `000NANANANANA 
Total wages/salary Rs m9271,0301,1051,2361,440 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
NEULAND LABS INCOME DATA
Net Sales Rs m5,7005,2576,6687,6279,369 
Other income Rs m12453539161 
Total revenues Rs m5,7125,3026,7037,6669,530 
Gross profit Rs m1,0635045841,0191,464 
Depreciation Rs m192221259313397 
Interest Rs m211189157216179 
Profit before tax Rs m6721392035291,050 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2031939367247 
Profit after tax Rs m469121164162803 
Gross profit margin %18.79.68.813.415.6 
Effective tax rate %30.213.419.269.423.5 
Net profit margin %8.22.32.52.18.6 
NEULAND LABS BALANCE SHEET DATA
Current assets Rs m3,7504,4724,5355,1525,482 
Current liabilities Rs m2,8563,6693,2703,5763,730 
Net working cap to sales %15.715.319.020.718.7 
Current ratio x1.31.21.41.41.5 
Inventory Days Days4042373726 
Debtors Days Days1,1601,347898909848 
Net fixed assets Rs m5,1056,2426,7697,1587,753 
Share capital Rs m9090129129129 
"Free" reserves Rs m2,2582,3826,8646,9717,690 
Net worth Rs m2,3482,4726,9937,1007,819 
Long term debt Rs m2981,035607774881 
Total assets Rs m8,85610,71411,30412,31013,235 
Interest coverage x4.21.72.33.56.9 
Debt to equity ratio x0.10.40.10.10.1 
Sales to assets ratio x0.60.50.60.60.7 
Return on assets %7.72.92.83.17.4 
Return on equity %20.04.92.42.310.3 
Return on capital %33.49.44.79.514.1 
Exports to sales %76.475.072.568.077.8 
Imports to sales %15.719.125.220.929.5 
Exports (fob) Rs m4,3563,9444,8355,1877,292 
Imports (cif) Rs m8971,0021,6811,5932,765 
Fx inflow Rs m4,3563,9444,8355,1877,292 
Fx outflow Rs m1,0141,0021,6811,5932,765 
Net fx Rs m3,3422,9423,1543,5944,527 
NEULAND LABS CASH FLOW
From Operations Rs m 387 113 699 573 1,893 
From Investments Rs m -421 -1,163 -772 -487 -844 
From Financial Activity Rs m -1 1,049 120 -55 -1,137 
Net Cashflow Rs m -35 -2 47 33 -88 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 36.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 22.5%
FIIs 17.2%
ADR/GDR 0.0%
Free float 63.8%
Shareholders 22,412
Pledged promoter(s) holding 4.3%
 

Company Information

REGD OFF Sanali Info Park 'a' Block, Ground Floor 8-2-120/113, Road No.2 Banjara Hills, Hyderabad - 500034
E-MAIL ir@neulandlabs.com WEB www.neulandlabs.com
TEL 040-30211600 FAX 040-30211602
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 1984 BSE CODE: 524558 FV (Rs): 10 DIV YIELD (%): 0.2

Read: NEULAND LABS 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ZOTA HEALTH CARE  TRIMURTHI DRUGS  PARENT.DRUGS  ASTER DM HEALTHCARE  THEMIS MEDICARE  

Compare NEULAND LABS With:   ZOTA HEALTH CARE  TRIMURTHI DRUGS  PARENT.DRUGS  ASTER DM HEALTHCARE  THEMIS MEDICARE  

Compare NEULAND LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty Recover from Day's Low to End Flat; Adani Ports and Bajaj Auto Among Top Gainers(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session on a flat note.

Views on news

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS - TEVA PHARMA COMPARISON

COMPARE NEULAND LABS WITH

MARKET STATS